New York, 11 Jan - For now it seems that Trump's strategy has been successful: after repeatedly pointing his finger at the car companies, accused of bringing their systems abroad, there has been a turnaround , with FCA and Ford announcing investments in America. Well, now the president-elect seems to want to use the same strategy with the pharmaceutical companies, giants that have completed mergers with the intention of shifting their fiscal domicile and paying less taxes.
“I want pharmaceutical companies to return to the United States, we need more competitiveness. Our pharmaceutical industry has been a disaster,” Trump said during today's press conference from Trump Tower in New York, the first since his election last November 8. Pharmaceutical companies have often committed crimes by “getting away with it” and going unpunished, Trump added. For this reason – continued the Republican billionaire – it is essential to “establish new procedures on offers” in cases of mergers and acquisitions.
In reality, Barack Obama has already tried to stop the trend towards tax inversion of American pharmaceutical giants: last April he had approved a provision with which he had blocked the 160 billion dollar merger between Pfizer and the Irish Allergan. The deal would have guaranteed Pfizer, the American pharmaceutical giant, to benefit from Ireland's favorable corporate tax regime. Meanwhile, on Wall Street, the pharmaceutical sector has suffered the blow of Trump. The shares of the large listed groups are losing more than 1%, driving the New York Stock Exchange into the red.
A24-Pau
(RADIOCOR) 11-01-17 19:11:49 (0626) 5 NNNN – Il Sole 24 Ore Radiocor Plus
Related news: Trump's Comments Are Big Pharma's Nightmare
